Andreas Hadjimichael, 10% Owner at Karyopharm Therapeutics Inc. (KPTI), sold 2,039,886 shares at $5.00 ($9.6M) on 2019-02-26, disclosed to the SEC on 2019-02-27.
Open-market sale of $9.6M KPTI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.99 | 800,000 | $4.0M | 41.4% |
| 2 | $5.00 | 123,400 | $617K | 6.4% |
| 3 | $4.51 | 558,243 | $2.5M | 26.1% |
| 4 | $4.51 | 558,243 | $2.5M | 26.1% |
| Total | $4.73 avg | 2,039,886 | $9.6M | 100% |
| Filing → |
| KPTI | SELL | 2016-06-27 | $302K | — | Filing → |
| KPTI | SELL | 2016-05-23 | $298K | — | Filing → |
| KPTI | SELL | 2016-05-12 | $362K | — | Filing → |